502 related articles for article (PubMed ID: 16413710)
1. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers.
Xu X; Sun M; Zhi F; Hu Y
Int J Pharm; 2006 Mar; 310(1-2):139-45. PubMed ID: 16413710
[TBL] [Abstract][Full Text] [Related]
2. Gastric floating matrix tablets: design and optimization using combination of polymers.
Prajapati ST; Patel LD; Patel DM
Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
[TBL] [Abstract][Full Text] [Related]
3. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
4. Design and evaluation of floating multi-layer coated tablets based on gas formation.
Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium bicarbonate on the properties of metronidazole floating matrix tablets.
Gutiérrez-Sánchez PE; Hernández-León A; Villafuerte-Robles L
Drug Dev Ind Pharm; 2008 Feb; 34(2):171-80. PubMed ID: 18302036
[TBL] [Abstract][Full Text] [Related]
6. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
[TBL] [Abstract][Full Text] [Related]
7. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
Petrovic A; Cvetkovic N; Ibric S; Trajkovic S; Djuric Z; Popadic D; Popovic R
Arch Pharm Res; 2009 Dec; 32(12):1767-74. PubMed ID: 20162406
[TBL] [Abstract][Full Text] [Related]
8. Floating matrix dosage form for dextromethorphan hydrobromide based on gas forming technique: in vitro and in vivo evaluation in healthy volunteers.
Hu L; Li L; Yang X; Liu W; Yang J; Jia Y; Shang C; Xu H
Eur J Pharm Sci; 2011 Jan; 42(1-2):99-105. PubMed ID: 21050887
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of a gastroretentive dosage form of labetalol hydrochloride.
Garse H; Vij M; Yamgar M; Kadam V; Hirlekar R
Arch Pharm Res; 2010 Mar; 33(3):405-10. PubMed ID: 20361305
[TBL] [Abstract][Full Text] [Related]
10. Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride.
Basak SC; Rahman J; Ramalingam M
Pharmazie; 2007 Feb; 62(2):145-8. PubMed ID: 17341036
[TBL] [Abstract][Full Text] [Related]
11. Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets.
Asnaashari S; Khoei NS; Zarrintan MH; Adibkia K; Javadzadeh Y
Pharm Dev Technol; 2011 Aug; 16(4):400-7. PubMed ID: 20429828
[TBL] [Abstract][Full Text] [Related]
12. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
Hu LD; Liu Y; Tang X; Zhang Q
Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
[TBL] [Abstract][Full Text] [Related]
15. Preparation of multiple-unit floating-bioadhesive cooperative minitablets for improving the oral bioavailability of famotidine in rats.
Zhu X; Qi X; Wu Z; Zhang Z; Xing J; Li X
Drug Deliv; 2014 Sep; 21(6):459-66. PubMed ID: 24456044
[TBL] [Abstract][Full Text] [Related]
16. Sustained delivery of captopril from floating matrix tablets.
Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
[TBL] [Abstract][Full Text] [Related]
17. Design and in vitro/in vivo evaluation of sustained-release floating tablets of itopride hydrochloride.
Ahmed SM; Ahmed Ali A; Ali AM; Hassan OA
Drug Des Devel Ther; 2016; 10():4061-4071. PubMed ID: 28008229
[TBL] [Abstract][Full Text] [Related]
18. [Studies on nimodipine sustained-release tablet capable of floating on gastric fluid with prolonged gastric resident time].
Wu W; Zhou Q; Zhang HB; Ma GD; Fu CD
Yao Xue Xue Bao; 1997 Oct; 32(10):786-90. PubMed ID: 11596225
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of gastroretentive controlled release tablets of alfuzosin hydrochloride.
Rudraswamy-Math NR; Gupta VR
Pak J Pharm Sci; 2015 Nov; 28(6):2147-52. PubMed ID: 26639508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
